Name: Latest research reports of Solara Active Pharma Sciences Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Solara Active Pharma Sciences Ltd.
Rating: 5
Author: Motilal Oswal

Solara Active Pharma Sciences Ltd.

NSE: SOLARA | BSE: 541540 | ISIN: INE624Z01016 | Industry: Pharmaceuticals
| Mid-range Performer

652.3500 15.30 (2.40%)

NSE Jul 01, 2025 15:31 PM

26.10% Fall from 52W High

Volume: 200.2K

Solara Active Pharma Sciences Ltd.

04 Aug 2021

652.35

2.40%

Comprehensive approach in API/CRAMS to drive growth

Buy: Solara Active Pharma Scien...

Motilal Oswal

Comprehensive approach in API/CRAMS to drive growth Motilal Oswal values your support in the Asiamoney Brokers Poll 2021 for India Research, Sales, Corporate Access and...

Number of FII/FPI investors decreased from 75 to 67 in Mar 2025 qtr

The Baseline | 01 Jul 2025, 06:15PM

Market closes flat, TVS Motor's total wholesales grow 20% YoY to 4 lakh units in June

Trendlyne Marketwatch | 01 Jul 2025, 03:53PM

Earnings Call Transcript - Q1FY21 for Solara Active Pharma Sciences

| 03 Aug 2020